Caricamento...
The fourth pillar: Despite some setbacks in the clinic, immunotherapy has made notable progress toward becoming an additional therapeutic option against cancer
Immunotherapy based on anti‐cancer vaccines and checkpoint inhibitors of the immune system could become the fourth therapeutic approach to treat cancer. It still requires a better understanding of how and against which cancers it is most efficient. [Image: see text]
Salvato in:
| Pubblicato in: | EMBO Rep |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5666595/ https://ncbi.nlm.nih.gov/pubmed/29021204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201745172 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|